Cellular aspects of vasculitis - T cell-mediated aspects

Springer Seminars in Immunopathology

Volumn 23, Issue 3, 2001, Pages 287-298

  Griffith, M E ^a   Pusey, C D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD52 ANTIGEN; CD86 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; RANTES; T LYMPHOCYTE RECEPTOR; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; KIDNEY BIOPSY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VASCULITIS; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOIMMUNE DISEASES; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MYELOBLASTIN; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES; VASCULITIS;

EID: 0034864312     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002810100077     Document Type: Review

References (70)

1. Cell-mediated autoimmunity in patients with Wegener's granulomatosis (WG)
2. T cells and macrophages in rapidly progressive glomerulonephritis: Clinicopathologic correlations
3. Giant cell vasculitis is a T cell-dependent disease
4. Endothelial cell activation in patients with systemic vasculitis
5. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders
6. Anti-myeloperoxidase-associated proliferative glomerulonephritis: An animal model
7. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG)
8. Molecular analysis of HLA class II genes in Goodpasture's disease
9. T lymphocyte adhesion mechanisms within inflamed human kidney: Studies with a Stamper-Woodruff assay
10. T cell activation in patients with ANCA-associated vasculitis: Inefficient immune suppression by therapy
11. In situ analysis of C-C chemokine mRNA in human glomerulonephritis
12. Cytokine profiles in Wegener's granulomatosis: Predominance of type 1 (Th1) in the granulomatous inflammation
13. Analysis of T cell responses to the autoantigen in Goodpasture's disease
14. HLA antigen frequencies in systemic vasculitis: Increase in HLA-DR2 in Wegener's granulomatosis
15. Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes
16. Use of proteinase 3 purified by reverse phase HPLC to detect autoantibodies in systemic vasculitis
17. Systernic vasculitis
18. T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitis
19. Expanded T cell populations in patients with Wegener's granulomatosis: Characteristics and correlates with disease activity
20. Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognise restricted epitopes of proteinase 3 involving the catalytic site
21. T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis
22. Classification, pathogenesis, and treatment of systemic vasculitis
23. HLA genes in ANCA-associated vasculitides
24. T-cell expansions with conserved T-cell receptor beta chain motifs in the peripheral blood of HLA-DRB1*0401 positive patients with necrotizing vasculitis
25. Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin
26. Decreased frequency of HLA DR6/DR13 in patients with Wegener's granulomatosis
27. Antigen-specific therapy for autoimmune disease
28. Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1 beta genes are associated with Wegener's granulomatosis
29. IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis
30. Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential
31. Association of Wegener's granulomatosis with HLA-B8
32. 11th International histocompatibility protocol for the HLA DNA-typing technique
33. T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission
34. Hybridomas from SCG/Kj mice produce p-ANCA with specificity for myeloperoxidase and induce proteinuria in nude mice
35. Genetic selection for crescentic formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis
36. Serum soluble interleukin 2 receptor levels in anti-neutrophil cytoplasmic autoantibodies-positive systemic vasculitis
37. Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies
38. + T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: Reversal with IL-10
39. T and B cell responses to neutrophil cytoplasmic antigens in systemic vasculitis
40. + T lymphocytes in response to Staphylococcus aureus in patients with Wegener's granulomatosis
41. Antibodies to proteinase 3 mediate expression of vascular cell adhesion molecule-1 (VCAM-1)
42. Costimulatory molecules in Wegener's granulomatosis (WG): Lack of expression of CD28 and preferential upregulation of its ligands B7-B1(CD80) and B7-2 (CD86) on T cells
43. Association between rapidly progressive glomerulonephritis and the properdin factor BfF and different HLA-D region products
44. Renal, major histocompatibility complex antigens and cellular components in rapidly progressive glomerulonephritis identified by monoclonal antibodies
45. HLA antigen frequencies and Wegener's granulomatosis
46. Glomerular vascular cell adhesion molecule-1 expression in renal vasculitis
47. Association of Wegener's granulomatosis with HLA antigens and other genetic markers
48. HLA class I/class II interaction in early onset pauciarticular juvenile chronic arthritis
49. Differential B- and T-cell activation in Wegener's granulomatosis
50. Cellular immune responses and pathogenesis in c-ANCA positive vasculitides
51. Intraglomerular and interstitial leukocyte infiltration, adhesion molecules, and interleukin-1 alpha expression in 15 cases of antineutrophil cytoplasmic autoantibody-associated renal vasculitis
52. Strong association between HLA-DRW2 and antibody-mediated Goodpasture's syndrome
53. Monoclonal antibody to CD40L prevents the development of experimental autoimmune glomerulonephritis
54. Oral administration of glomerular basement membrane prevents the development of experimental autoimmune glomerulonephritis in the WKY Rat
55. CD28-DB7 blockade prevents the development of experimental autoimmune glomerulonephritis
56. + T-cell subsets in Wegener's granulomatosis
57. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity
58. T cell receptor V beta repertoire in bronchoalveolar lavage in Wegener's granulomatosis and sarcoidosis
59. Peripheral blood T lymphocytes in systemic vasculitis: Increased T cell receptor V beta 2 gene usage in microscopic polyarteritis
60. HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens
61. Serum markers of T cell activation in relapses of Wegener's granulomatosis
62. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis
63. Vaccination with autoreactive T cell clones in multiple sclerosis: Overview of immunological and clinical data
64. HLA-A antigens of patients with Wegener's granulomatosis
65. The role of T cells in extracapillary glomerulonephritis
66. Autoantibody associations with MHC class II antigens in scleroderma and autoimmune vasculitis
67. In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG)
68. The role of the c-ANCA antigen in the pathogenesis of Wegener's granulomatosis. A hypothesis based on both humoral and cellular mechanisms
69. Distribution of MHC class II alleles in primary systemic vasculitis